A director at Rubis sold 349,709 shares at 34.236EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms First-quarter 2026 revenue reached €384m : +7.7% at constant exchange rate and scope (CERS) vs Q1 2025+2.2% at actual rates impacted by significant currency headwinds Balanced growth in both segments : companion animal +9.9% and farm animal +8.4% with a strong contribution from our Supercharge platforms (excl. Thyronorm) with an increase of around +15% at CERS.Solid volume/mix effect of ~+6%, completed by price increase of ~+2%Excellent Q1 2026 performance driven by exceptio...
Virbac: forte croissance de +7,7 % au premier trimestre 2026 à pcc, portée par la croissance à deux chiffres de nos plateformes prioritaires Supercharge⁴ Le chiffre d'affaires du premier trimestre 2026 a atteint 384 M€ : +7,7 % à taux de change et périmètre constants par rapport au T1 2025.+2,2 % à taux réels, impactés par des effets de change significativement défavorables. Croissance équilibrée des deux segments : animaux de compagnie (+9,9 %) et animaux de production (+8,4 %), avec une forte contribution de nos plateformes Supercharge (hors Thyronorm) qui ont progressé d'environ +15 % à ...
A director at LNA Sante Sa bought 132,373 shares at 26.354EUR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Virbac : Declaration of the number of shares and voting rights 03/2026 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsMarch, 31 20268 390 660Gross total of voting rights : 12 707 254Net total* of voting rights : 12 694 4...
Virbac : Déclaration d'actions et de droits de votes 03/2026 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place cotation : Euronext ParisCompartiment ACode ISIN : FR0000031577 DATENombre total d’actions composant le capital socialNombre total de droits de vote31 mars 2026 8 390 660 Total brut de droits de vote : 12 707 254Total net* de droits de vote : 12 694 418 Total net* = nombre total de droits de vote attachés au ...
RUBIS: Information relating to the total number of voting rights and shares as of 31/03/2026 Paris, 2 April 2026, 5:45 pm INFORMATION ON TOTAL NUMBER OF VOTING RIGHTS AND NUMBER OF SHARES PURSUANT TO ARTICLE L.233-8 II OF THE FRENCH COMMERCIAL CODE AND ARTICLE 223-16 OF THE GENERAL REGULATION OF THE FRENCH FINANCIAL MARKETS AUTHORITY DateClass of sharesNumber of sharesNumber of theoretical voting rightsNumber of exercisable voting rights (excluding shares bought back by the Company (deprived of voting rights) and shares deprived of voting rights in accordance with art. L. 233-14 o...
RUBIS: Déclaration de capital et de droits de vote au 31/03/2026 Paris, le 2 avril 2026, 17h45 INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS PRÉVUES PAR L’ARTICLE L. 233-8 II DU CODE DE COMMERCE ET L’ARTICLE 223-16 DU RÈGLEMENT GÉNÉRAL DE L’AUTORITÉ DES MARCHÉS FINANCIERS Date Catégorie d’actions Nombre d’actions Nombre de droits de vote théoriques Nombre de droits de vote exerçables(hors actions autodétenues (privées du droit de vote) et actions privées du droit de vote conformément à l’article L. 233-14 du Code de commerce) 31 mars 202...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.